Cite
HARVARD Citation
Alderson, D. et al. (n.d.). Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. Lancet oncology. 18 (9), pp. 1249-1260. [Online].